M. GADEWAR and B. LAL, “MOLECULAR DOCKING AND SCREENING OF DRUGS FOR 6LU7 PROTEASE INHIBITOR AS A POTENTIAL TARGET FOR COVID-19”, Int J App Pharm, vol. 14, no. 1, pp. 100–105, Jan. 2022.